We are live on
!
Find out more
PI
Pennant Investors Portfolio holdings
AUM
$335M
1-Year Est. Return
97.32%
This Fund
S&P 500
This Quarter
Est. Return
+13.88%
1 Year Est. Return
+97.32%
3 Year Est. Return
+371.91%
5 Year Est. Return
+311.35%
10 Year Est. Return
–
AUM
$458M
AUM Growth
+$181M
(+65%)
Cap. Flow
+$17.2M
Cap. Flow
% of AUM
3.76%
Top 10 Holdings %
Top 10 Hldgs %
94.72%
Holding
45
New
32
Increased
1
Reduced
–
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ECHO
EchoStar
ECHO
|
+$27.7M |
| 2 |
Perimeter Solutions
PRM
|
+$2.69M |
| 3 |
Zentalis Pharmaceuticals
ZNTL
|
+$473K |
| 4 |
Arcutis Biotherapeutics
ARQT
|
+$465K |
| 5 |
KYNB
Kyntra Bio
KYNB
|
+$464K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DISH
DISH Network Corp.
DISH
|
+$24.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 28.96% |
| 2 | Communication Services | 19.22% |
| 3 | Consumer Discretionary | 16.46% |
| 4 | Technology | 16.31% |
| 5 | Industrials | 9.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
PUT
Apple
AAPL
$4.85T
| $121M | 26.48% |
+630,000
| New | +$116M |
|
2
Amazon
AMZN
$2.65T
| $52.9M | 11.54% |
348,000
| – | – |
|
3
Alphabet (Google) Class A
GOOGL
$4.19T
| $52.4M | 11.44% |
375,000
| – | – |
|
4
Microsoft
MSFT
$3.64T
| $48.5M | 10.59% |
129,000
| – | – |
|
5
TransDigm Group
TDG
$59.7B
| $42.5M | 9.28% |
42,000
| – | – |
|
|
ECHO
6
EchoStar
ECHO
$27.1B
| $35.7M | 7.79% |
+2,153,209
| New | +$27.7M |
|
7
Micron Technology
MU
$1.05T
| $26.1M | 5.7% |
306,000
| – | – |
|
|
ODP
8
DELISTED
ODP
ODP
| $22.5M | 4.92% |
400,000
| – | – |
|
9
Antero Resources
AR
$11B
| $20.7M | 4.52% |
913,000
| – | – |
|
|
10
CALL
Antero Resources
AR
$11B
| $11.3M | 2.48% |
500,000
| – | – |
|
|
11
Perimeter Solutions
PRM
$5.22B
| $10.6M | 2.31% |
2,300,000
+700,000
| +44% | +$2.69M |
|
12
Altimmune
ALT
$630M
| $1.24M | 0.27% |
+109,800
| New | +$458K |
|
|
KYNB
13
Kyntra Bio
KYNB
$30.8M
| $681K | 0.15% |
+30,736
| New | +$464K |
|
14
Nurix Therapeutics
NRIX
$2.61B
| $586K | 0.13% |
+56,800
| New | +$389K |
|
15
Coherus Oncology
CHRS
$188M
| $560K | 0.12% |
+168,100
| New | +$450K |
|
|
16
Arcutis Biotherapeutics
ARQT
$3.29B
| $552K | 0.12% |
+170,900
| New | +$465K |
|
17
Fate Therapeutics
FATE
$292M
| $546K | 0.12% |
+146,100
| New | +$345K |
|
|
IGMS
18
DELISTED
IGM Biosciences
IGMS
| $539K | 0.12% |
+64,900
| New | +$377K |
|
|
ALLK
19
DELISTED
Allakos
ALLK
| $508K | 0.11% |
+186,100
| New | +$419K |
|
20
Travere Therapeutics
TVTX
$5.98B
| $502K | 0.11% |
+55,800
| New | +$406K |
|
|
ETNB
21
DELISTED
89bio
ETNB
| $497K | 0.11% |
+44,500
| New | +$409K |
|
|
22
Zentalis Pharmaceuticals
ZNTL
$293M
| $491K | 0.11% |
+32,400
| New | +$473K |
|
23
Relay Therapeutics
RLAY
$4.13B
| $467K | 0.1% |
+42,400
| New | +$358K |
|
24
Arcus Biosciences
RCUS
$3.14B
| $453K | 0.1% |
+23,700
| New | +$379K |
|
25
MacroGenics
MGNX
$260M
| $421K | 0.09% |
+43,800
| New | +$303K |
|
Similar funds
TFA
SIM
PAP
SS
BIA
TODC
JWM
AWS
Pennant Investors's Q4 2023 Portfolio in Review
As of Q4 2023, Pennant Investors held 45 positions worth $458M, up 65% from $277M the previous quarter. Its ten largest holdings account for 95% of the portfolio.
Pennant Investors deployed $17.2M of net new capital in Q4 2023, opening 32 new positions and adding to 1 existing holding. Its largest new stake was EchoStar: 2,153,209 shares worth $35.7M.
By sector, the portfolio is most concentrated in Miscellaneous at 29% of assets, up from 4.6% a quarter earlier, followed by Communication Services and Consumer Discretionary.
On the sell side, the most notable exit was DISH Network Corp., an estimated $24.3M sold.
- Pennant Investors's largest Q4 2023 buy was EchoStar: 2,153,209 shares worth $35.7M.
- Pennant Investors added most to Perimeter Solutions in Q4 2023, an estimated $2.69M increase.
- Pennant Investors fully exited DISH Network Corp. in Q4 2023, selling an estimated $24.3M.
- Pennant Investors's ten largest holdings make up 95% of its $458M portfolio in Q4 2023.
- Pennant Investors opened 32 new positions and closed 1 in Q4 2023.
- Pennant Investors's portfolio value rose 65% quarter-over-quarter to $458M.
Based on Pennant Investors's 13F filing for Q4 2023, filed 14 Feb 2024.